Accounting Manager

The role

The Accounting Manager will own day-to-day accounting operations and support the month-end close process. This role involves preparing clinical trial accruals and supporting internal controls and financial reporting for a clinical-stage biotechnology company.

What you will do

• Support the monthly accounting close process.
• Support FP&A budget to actual reporting.
• Review journal entries and reconciliations prepared by accounting team members.
• Supervise, mentor, and develop junior accounting staff.
• Own clinical trial accrual preparation.
• Liaise with internal stakeholders and clinical vendors.
• Implement policies and procedures for accounting activities and functions.
• Maintain internal controls in areas of responsibility.
• Support annual audits, quarterly financial reviews, and internal controls testing.
• Support system implementations and other projects.

Required qualifications

• 5+ years of progressive finance and accounting experience
• Bachelor’s degree in accounting or related field
• Deep technical accounting knowledge (US GAAP), including R&D accruals and clinical trial accounting
• Advanced proficiency in Microsoft Excel (XLOOKUP, INDEX/MATCH, etc.)
• Strong knowledge of public company requirements, internal controls (SOX), and cross-functional alignment
• Experience supporting Big 4 or national firm audits
• Excellent judgment, high integrity, and the ability to operate in a fast-moving environment
• Strong written and verbal communication skills
• Ability to thrive in a fast-paced, dynamic environment and remain comfortable with change and ambiguity
• Flexible, proactive, and hands-on mindset

Nice to have

• Publicly traded, pre-IPO, or clinical stage biotech/life sciences companies
• CPA license
• Public accounting experience
• Experience with NetSuite

Benefits

• Annual bonus
• Equity
• Comprehensive benefits offering

Before you apply

• Braveheart participates in the federal E-Verify program to confirm employment authorization for all new hires.

About the company

Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.